You are here : Home > Resources and skills > Nano-biotechnology platform

Article | Software technologies


Technologies for healthcare platforms

Nano-biotechnology platform

Published on 29 April 2016

R&D FOR ALL BIOTECHNOLOGY APPLICATIONS

The 5,500 sq. m nano-biotechnology platform is home to a complete range of medical-systems development know-how, from sample surface preparation, biological analysis, and substrate functionalization through to packaging, microfluidics, microsystems, biological detection systems, and component readers.

The platform’s R&D benefits scientific researchers, hospitals, and biomedical companies.

With X-ray, gamma-ray, fluorescence, visible, and lensless imaging solutions, the platform can be used to study living organisms, tissues, cells, and bacteria.

The platform’s microsystems meet the new needs of personalized medicine, nanomedicine, and remote diagnostics and can be implemented in vivo, embedded, and implanted into medical devices.

The platform is located next to Clinatec and the Bioscience and Biotechnology Institute of Grenoble (BIG) and leverages BIG’s basic research. The platform files around 35 patents per year, including for solutions developed under R&D contracts with some 30 industrial partners.

> Access to: ALL TECHNOLOGY PLATFORMS


OUR Technologies

thumbnail-micro-and-nanotechnology-for-healthcare.jpg

ALL TECHNOLOGIES


NOTABLE EQUIPMENT

25 pieces of heavy equipment: X-ray measurement chambers, screen-printing machines, stamping and machining equipment, etc.

KEY FIGURES

  • 5,500 sq. m of facilities, including 2,500 sq. m of labs and clean rooms
  • 200 employees
  • € 6 million in equipment
  • 35 patents filed per year

PARTNERS

Around 30 industrial partners, including Fluoptics, Trixell, and Horiba

LOCATION

Leti (Grenoble)

More information

CEA Tech technology-platforms-booklet



How to collaborate with CEA Tech teams ?